Free tool
FAERS Monitor: Vigamox
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021598 or its brand name (Vigamox, Moxifloxacin Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
6,747
Serious
5,884
87% of reports
Hospitalization
2,130
Death reported
767
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- asthma1,340
- drug hypersensitivity1,158
- dyspnoea1,134
- off label use1,078
- pain1,069
- wheezing1,018
- pneumonia968
- rash908
- vomiting881
- drug ineffective840
- fatigue752
- malaise731
- hypertension719
- headache695
- hypersensitivity683
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 32 |
| 2005 | 67 |
| 2006 | 112 |
| 2007 | 69 |
| 2008 | 42 |
| 2009 | 55 |
| 2010 | 101 |
| 2011 | 104 |
| 2012 | 210 |
| 2013 | 127 |
| 2014 | 195 |
| 2015 | 167 |
| 2016 | 240 |
| 2017 | 272 |
| 2018 | 334 |
| 2019 | 365 |
| 2020 | 464 |
| 2021 | 455 |
| 2022 | 574 |
| 2023 | 720 |
| 2024 | 787 |
| 2025 | 741 |
| 2026 | 514 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,047,412 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| wheezingSignal | 1,018 | 54.4 | 51.4 | 52,573 |
| asthmaSignal | 1,340 | 37.4 | 35.6 | 47,118 |
| drug hypersensitivitySignal | 1,158 | 18.8 | 17.8 | 19,515 |
| hypersensitivitySignal | 683 | 11.5 | 10.7 | 6,577 |
| hypertensionSignal | 719 | 10.6 | 9.9 | 6,295 |
| pneumoniaSignal | 968 | 9.3 | 8.8 | 7,296 |
| rashSignal | 908 | 6.5 | 6.1 | 4,305 |
| dyspnoeaSignal | 1,134 | 6.3 | 5.9 | 5,130 |
| vomitingSignal | 881 | 5.9 | 5.5 | 3,612 |
| painSignal | 1,069 | 5.4 | 5.1 | 3,971 |
| malaiseSignal | 731 | 5.2 | 4.9 | 2,526 |
| off label useSignal | 1,078 | 3.8 | 3.6 | 2,358 |
| headacheSignal | 695 | 3.5 | 3.2 | 1,248 |
| fatigueSignal | 752 | 3.0 | 2.8 | 1,047 |
| drug ineffective | 840 | 2.0 | 1.9 | 438 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.